Differential Signaling through p190 and p210 Forms of BCR-ABL Fusion Proteins Revealed By Proteomic Analysis

被引：0

作者：

Cutler, Jevon ^{[1
]}

Tahir, Rahia ^{[1
]}

Han, Jingnan ^{[1
]}

Nirujogi, Raja Sekhar ^{[1
]}

Huang, Tai-Chung ^{[2
]}

Wong, Xianrong ^{[3
]}

Mallampati, Saradhi ^{[4
]}

Sun, Xiaoping ^{[4
]}

Brown, Patrick ^{[5
]}

Reddy, Karen ^{[3
]}

Pandey, Akhilesh ^{[1
,6
,7
,8
]}

机构：

[1] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA

[2] Natl Taiwan Univ Hosp & Canc Ctr, Dept Internal Med, Div Hematol, Taipei, Taiwan

[3] Johns Hopkins Univ, Dept Biol Chem, Ctr Epigenet, Baltimore, MD USA

[4] Univ Texas MD Anderson Canc Ctr, Lab Med, Houston, TX 77030 USA

[5] Johns Hopkins Univ, Sch Med, Pediat Oncol, Baltimore, MD USA

[6] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA

[7] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA

[8] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：2

共 50 条

[21] BCR/ABL p210, p190 and p230 fusion genes in 250 Mexican patients with chronic myeloid leukaemia (CML)
Arana-Trejo, RM
Sánchez, ER
Ignacio-Ibarra, G
de la Fuente, EB
Garces, O
Morales, EG
Granados, MC
Martínez, RO
Rubio-Borja, ME
Anaya, LS
Herrera, P
Llamas, JD
Kofman, S
CLINICAL AND LABORATORY HAEMATOLOGY, 2002, 24 (03): : 145 - 150
[22] TYROSINE PHOSPHORYLATION OF P160 BCR BY P210 BCR-ABL
LU, D
LIU, JX
CAMPBELL, M
GUO, JQ
HEISTERKAMP, N
GROFFEN, J
CANAANI, E
ARLINGHAUS, R
BLOOD, 1993, 82 (04) : 1257 - 1263
[23] 融合基因BCR-ABL(P190、P210、P230)对ALL和CML的鉴别诊断价值
翁明明
周邮
陶晓军
吉林医学, 2024, 45 (07) : 1615 - 1618
[24] Coexistence of P190 and P210 BCR/ABL transcripts in chronic myeloid leukemia blast crisis resistant to imatinib
Zhao Junmei
Yu Fengkuan
Song Yongping
Fang Baijun
Liu Yuzhang
Liu Lina
Zhang Qinglan
SPRINGERPLUS, 2015, 4
[25] New practice of BCR::ABL1 standardization system based on p210 and p190 BCR::ABL1 reference materials
Ma, Yu
Han, Yanxi
Diao, Zhenli
Chen, Yuqing
Huang, Tao
Feng, Lei
Jiang, Jian
Zhang, Yuanfeng
Li, Jinming
Zhang, Rui
CLINICA CHIMICA ACTA, 2025, 565
[26] THE TARGETABLE ROLE OF HAUSP IN P190 BCR-ABL LEUKEMIA
Carra, G.
Panuzzo, C.
Crivellaro, S.
Morena, D.
Lingua, M. F.
Taulli, R.
Guerrasio, A.
Saglio, G.
Morotti, A.
HAEMATOLOGICA, 2016, 101 : S66 - S67
[27] HETEROGENEITY IN LINEAGE DERIVATION OF PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA EXPRESSING P190(BCR-ABL) OR P210(BCR-ABL) - DETERMINATION BY ANALYSIS OF INDIVIDUAL COLONIES WITH THE POLYMERASE CHAIN-REACTION
ESTROV, Z
TALPAZ, M
KANTARJIAN, HM
ZIPF, TF
MCCLAIN, KL
KURZROCK, R
CANCER RESEARCH, 1993, 53 (14) : 3289 - 3293
[28] Chronic myeloid leukemia with p210 BCR-ABL and monocytosis
Dass, Jasmita
Jain, Sonal
Tyagi, Seema
Sazawal, Sudha
LEUKEMIA & LYMPHOMA, 2011, 52 (07) : 1380 - 1381
[29] BCR-ABL p210 and p190 induce constitutive activation of Stat5 in human and murine factor-dependent cell lines
DusanterFourt, I
Ahmed, A
Bennardo, T
Issad, C
Varet, B
Vainchenker, W
Turhan, AG
BLOOD, 1995, 86 (10) : 651 - 651
[30] Expression of P190 and P210 BCR-ABL in CML-derived CD34+, CD34+ and CD15+
Carlo-Stella, C
Savoldo, B
Sammarelli, G
Garau, D
Regazzi, E
Cilloni, D
De Micheli, D
Rizzoli, V
Saglio, G
EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 758 - 758

← 1 2 3 4 5 →